Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Yuhas

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Radiation Research|November 1, 1974
Recovery from radiation-carcinogenic injury to the mouse ovaryJ M Yuhas
Cancer Treatment Reports|June 1, 1979
Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamineJ M Yuhas
Radiation Research|August 1, 1971
Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50(7) dosesJ M Yuhas
Cancer Research|May 1, 1980
Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acidJ M Yuhas
British Journal of Cancer|July 1, 1979
Misonidazole enhancement of acute and late radiation injury to the rat spinal cordJ M Yuhas
Experimental Gerontology|October 1, 1971
Age and susceptibility to reduction in life expectancy: an analysis of proposed mechanismsJ M Yuhas
Cancer Research|September 1, 1980
Correspondence re: E. H. Perkins and L. H. Cacheiro. immunodepression, a noncontributor to radiation-induced leukemogenesis of the RFM mouse. Cancer Res., 40: 357-361, 1980J M Yuhas
Cellular Immunology|July 1, 1972
Radioprotective and toxic effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on the development of immunocompetent cellsJ M Yuhas
Radiation Research|December 1, 1970
Biological factors affecting the radioprotective efficiency of S-2-[2-aminopropylamino] ethylphosphorothioic acid (WR-2721). LD50(3)) dosesJ M Yuhas
International Journal of Radiation Oncology, Biology, Physics|April 1, 1983
Efficacy testing of WR-2721 in Great Britain everything is black and white at the gray labJ M Yuhas
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Radiation Research|November 1, 1974
Recovery from radiation-carcinogenic injury to the mouse ovaryJ M Yuhas
Cancer Treatment Reports|June 1, 1979
Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamineJ M Yuhas
Radiation Research|August 1, 1971
Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino]ethylphosphorothioic acid (WR-2721): LD 50(7) dosesJ M Yuhas
Cancer Research|May 1, 1980
Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2-(3-aminopropylamino)-ethylphosphorothioic acidJ M Yuhas
British Journal of Cancer|July 1, 1979
Misonidazole enhancement of acute and late radiation injury to the rat spinal cordJ M Yuhas
Experimental Gerontology|October 1, 1971
Age and susceptibility to reduction in life expectancy: an analysis of proposed mechanismsJ M Yuhas
Cancer Research|September 1, 1980
Correspondence re: E. H. Perkins and L. H. Cacheiro. immunodepression, a noncontributor to radiation-induced leukemogenesis of the RFM mouse. Cancer Res., 40: 357-361, 1980J M Yuhas
Cellular Immunology|July 1, 1972
Radioprotective and toxic effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721) on the development of immunocompetent cellsJ M Yuhas
Radiation Research|December 1, 1970
Biological factors affecting the radioprotective efficiency of S-2-[2-aminopropylamino] ethylphosphorothioic acid (WR-2721). LD50(3)) dosesJ M Yuhas
International Journal of Radiation Oncology, Biology, Physics|April 1, 1983
Efficacy testing of WR-2721 in Great Britain everything is black and white at the gray labJ M Yuhas
Pageof 8